Pre-Prostatectomy Lovastatin on Prostate Cancer

NCT01478828 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped The study was stopped due to an unanticipated serious adverse event.

Conditions

Prostate Cancer

Interventions

DRUG: Lovastatin

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]